A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...

A prescription medication that has been available in the U.S. since 1992 might have another significant benefit.

Subset analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis in difficult-to-treat MASH patientsBoth artificial ...

Several studies have shown that niacin can significantly reduce the level of low-density lipoprotein cholesterol (bad ...

The surprising things your heart doctor really thinks about your weight, your red wine habit, and more. The post 25 ...

In this new research, scientists analyzed data from electronic health records covering over 900,000 patients. The study ...

KEY BUSINESS HIGHLIGHTSPhase 2a clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease expected to ...

A new study found that many people on Medicare with low to moderate incomes don't have enough money to pay for a hospital ...

These patients had conditions such as diabetes, very high cholesterol, or a history of strokes ... and Vitamin K2 could help reduce heart disease risk. For more information about heart health, please ...

Total cholesterol, glucose, done. But I never knew to ask for anything beyond ... They’re tracking over a hundred ...

1, 2026. MORE: Trump calls US 'garbage can for the world' in latest anti-immigrant rhetoric Patients are to be told that the collection of this information will not affect patient care ...

Patients have the right to withhold the information and hospital workers must tell them their responses will not affect their care, as required by federal law. Tracking hospital costs and patient ...